HOW ARCHIMED SECURED AN ASSOCIATE FOR THEIR FIRM IN NEW YORK
January 6, 2022
At A Glance
The new Associate will be joining the ArchiMed team based out of New York, US.
REASON FOR THE SEARCH
The firm has experienced continuous growth and is raising a new fund this year. They are wanting to bring an Associate Director into the firm to help support and assist with fundraising and investments.
THE PRIVATE EQUITY FIRM
ArchiMed, established in 2014 by 3i Corporation Healthcare leaders, is a healthcare-focused investment company based in Lyon, France, and New York. They invest globally in Biopharma, MedTech, Medical Devices, and other healthcare sectors. With €1.7BN AUM, they manage the third fund of €800M (raised in 2018) and are currently raising the Med 3 fund (target: €600M). Their international team of 40 members from 11 nationalities drives business growth through acquisitions and expansion. Recent investments include Bomi and Direct Healthcare Group in 2019.
REQUIREMENT
- Any Healthcare investment experience (preferred), but any sector considered
- Very good financial due diligence & financial modeling skills
- Located in New York
- At least 2 years of Private Equity experience
- Internship in Private Equity
- Driven
- Motivated
- Humble
- Keen to improve skills
- Able to take criticism
- Willing to learn
WHY RAW SELECTION
The main challenge throughout this search for an Associate was finding someone who would happily move to the US.
Many candidates were hesitant about the move to New York and joining a firm that was headquartered in Europe.
Raw Selection overcame this challenge by providing each candidate with a detailed engagement pack on the firm’s mission, long-term plan, and key selling points to make the role a more attractive offer.
THE PROCESS
Raw Selection commences every search by discussing and understanding the full search requirements and brief. Raw Selection’s Senior Associate, Haleema Hussain, led the search and worked with Managing Partner, Alex Rawlings, who, with the cooperation of Andre-Michel Ballester, the hiring manager at ArchiMed, built out a full picture of the company, the employees, the culture, and exactly the type of profile that was needed to succeed in this position.
Raw Selection followed their extensive 15-step search process and identified an exceptional individual in just 1 week who was subsequently hired for the role.
Since this search, they have been able to assist ArchiMed in multiple searches for their team in New York and Lyon.
THOUGHTS ON THE SEARCH
Overall, this search for ArchiMed was successful, as they secured excellent talent to help the growth of their new office in the US.
This addition to the ArchiMed team in New York will help grow the firm's investments across the globe.
Since this search for an Associate Director, Raw Selection has helped ArchiMed secure an Impact Director to support ESG initiatives and their charity foundation, The Eureka Foundation.
GET IN TOUCH
About Raw Selection: Raw Selection favors a meticulous approach to candidate research. Their process for selecting the right candidate means they can boast a 100% success rate for all their retained clients, with 96% of placed candidates still in their role after 12 months.
If you are looking for a new role within the Private Equity sector, please get in contact with Haleema at haleema.hussains@raw-selection.com.
Benefits
Get in Touch
Raw Selection favors a meticulous approach to talent research. Our process for selecting the right talent means we can boast a 100% success rate for all our retained and engaged C-Suite clients, with 96% of placed candidates still in their roles after 12 months.
If you are looking for new talent, contact us now.
May 19, 2025
Case Study
HOW CEIBA CAPITAL PARTNERS SECURED A CFO FOR THEIR PORTFOLIO COMPANY, NANO HEARING AIDS
February 3, 2025
Case Study
HOW HERITAGE HOLDING SECURED A PRINCIPAL FOR THEIR TEAM IN BOSTON, MASSACHUSETTS
November 19, 2024
Case Study
HOW CONTINUIM EQUITY PARTNERS SECURED A BD MANAGER/HEAD OF SALES FOR THEIR PORTFOLIO COMPANY, KOTTLER METAL IN THE US
October 30, 2024
Case Study